How foam dressings are used for chronic wounds in a Milan primary care center

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will enroll around 40 adult outpatients with chronic wounds at a Milan primary care center who are currently treated with a foam dressing. Eligible participants will switch to Mepilex Border Flex and are followed for roughly four weeks to observe routine wound-care outcomes. The trial is conducted in a real-world primary care setting with data collected during standard follow-up visits. Outcomes will reflect practicality, safety, and short-term wound-closure indicators in everyday clinical practice. No randomization or control group is described.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years or older.
* The patient has been deemed by the HCP to change dressing to Mepilex® Border Flex.
* Patients with chronic wounds treated with foam dressings, other that Mepilex® Border Flex, according to its intended use at baseline visit for minimum 4 weeks.
* Patients with an expectation of wound follow-up of at least 4 weeks.
* Patients agreeing to only have the dressing changed by the HCP.
* Patients capable of signing the Informed Consent Form and answer the questions being asked.

Exclusion Criteria:

* Patients with any applicable contraindication or sensibilization to any of the dressing compounds
* Patients with pressure ulcers (PU) stage I, deep tissue injuries or terminal wounds (e.g., fungating wounds)
* Patients with wounds whose location and/or aetiology requires a dressing change for reasons that are unrelated to the dressing characteristics such as wounds in the sacral area
* Hospice patients
* Patients participating in other studies interfering with this study
* Patients who have been diagnosed as cognitively impaired

Where it's running

• Niguarda Hospital
  Milan, Niguarda, Italy Recruiting

Study contacts

• Study coordinator: Fia Navntoft
• Email: Fia.navntoft@molnlycke.com
• Phone: +4544141446

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tropocells autologous platelet-rich fibrin for healing mild-to-moderate neuroischemic diabetic foot ulcers

  This will test whether Tropocells autologous platelet-rich fibrin (PRF) helps close mild-to-moderate neuroischemic diabetic foot ulcers in adults with type 1 or type 2 diabetes.

  Recruiting at 2 sites Phase 2 Estar Medical dba Medical Technologies, LTD · Corpus Christi, Texas and 1 other locations · NCT06810726

• Observational Registry for Dezawa MuseCells Outcomes

  This project follows people who were treated with Dezawa MuseCells to see how they’re doing over 5 years using online surveys.

  Recruiting at 2 sites MuseCell Innovations Pte LTD · North Palm Beach, Florida and 1 other locations · NCT07645989

• Immersive virtual reality to reduce wound‑care pain in long‑term care residents (pilot)

  This pilot will try immersive virtual reality headsets during dressing changes to see if VR reduces pain and distress for long‑term care residents with pressure ulcers.

  Recruiting McGill University · Montreal, Quebec and 1 other locations · NCT07447830

• Comparing Ioband® waterproof dressing to standard dressing after knee surgery

  This study is testing whether a new waterproof dressing called Ioband® works better than a standard dressing for people recovering from knee surgery by seeing if it needs to be changed less often and if patients are happier with it.

  Recruiting at 2 sites Thammasat University Hospital · Pathum Thani, Khlong luang and 1 other locations · NCT06943053

• Using Miro3D Wound Matrix to Heal Diabetic Foot Ulcers

  This study is testing if adding a special wound dressing called Miro3D to regular care can help people with early-stage diabetic foot ulcers heal faster.

  Recruiting Reprise Biomedical, Inc. · Coconut Creek, Florida and 2 other locations · NCT06939686

• MIMOSA Pro near-infrared tissue oxygen imaging compared with standard leg vascular tests

  This project tries to see if the MIMOSA Pro near‑infrared camera can measure leg tissue oxygen as well as standard vascular tests in adults having lower‑limb vascular assessments.

  Recruiting MIMOSA Diagnostics Inc. · Lake Success, New York · NCT06899113

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.